(Source: MELA Sciences Inc) IRVINGTON, N.Y., October 2, 2013 - MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that developed and is commercializing MelaFind®, the first and only FDA-approved optical diagnostic device for melanoma detection used by dermatologists in their fight against melanoma, will participate in the American Society of Dermatologic Surgery (ASDS) Annual Meeting from October 3-6, 2013, at the Hyatt Regency in Chicago, Illinois. The four-day event is an educational opportunity for the Society's dermatologists and dermatologic surgeons to stay abreast of innovative devices, news and technology. As part of the meeting, MELA Sciences' Interim Chief...
↧